Geriatric patients with CKD are at high risk for morbidity and mortality from the potential side effects of treatments.
A majority of patients on HD have hypertension, and CVD is the leading cause of death in these patients.
Elevated uric acid levels are associated with increased risks for hypertension, gout, and renal impairment.
Findings support expanded clinical use of this simple measurement.
Increased risk of serious fall injuries is particularly high in those with previous fall injuries.
Study found age was a factor in how quickly patients got treatment.
Almost two-thirds of those enrolled in health plans have been properly treated, but more must be done.
Mean sodium consumption more than twice the AHA recommended daily intake.
Molecular basis for this effect appears to involve nitric oxide metabolites stored in the skin.
Drinking green tea may lessen the effects of the antihypertensive medication nadolol (Corgard).
The condition is associated with a greater than six times increased likelihood of end-stage renal disease, study found.
Twelve weeks of continuous positive airway pressure decreased 24-hour mean and diastolic blood pressure.
Treatment shown to benefit patients with stage 3 or 4 CKD and treatment-resistant hypertension.
Both approaches are associated with similar outcomes in patients with renal artery stenosis and CKD or hypertension.
Greater proteinuria also associated with increased odds of masked and sustained hypertension.
The effect may be mediated by an acute reduction in sympathetic nervous system activity.
Blood pressure (BP) of 130-139/85-89 mm Hg is associated with a twofold increased risk compared with BP less than 120/80 mm Hg.
Only about a third of those treated achieve blood pressure control.